April 16, 2021
Towa Pharmaceutical filed an additional request in December 2020 with the Japan Patent Office seeking to invalidate a patent associated with Kowa’s hypercholesterolemia treatment Livalo OD Tablets (pitavastatin), it revealed on April 14. Regarding the Livalo generic, Kowa on March...read more